Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/25911| Title: | Intravenous rifampicin use in the management of amanita phalloides toxicity. | Austin Authors: | Zuker-Herman, Rona;Tong, Roger;Wong, Anselm Y | Affiliation: | Monash Toxicology and Emergency Department, Monash Health, Heidelberg, Australia Victorian Poisons Information Centre Toxicology Emergency |
Issue Date: | Sep-2021 | Date: | 2021-02-19 | Publication information: | Clinical Toxicology 2021; 59(9): 843-845 | Abstract: | Context: Amanita phalloides related toxicity from amatoxins can result in acute liver and multi-organ failure and is responsible for 90% of all mushroom poisoning death. However, more evidence is needed in regards to different management strategies. Case details: We present two cases of amanita mushroom ingestion who were treated with intravenous rifampicin. Discussion: Further study is needed to establish the efficacy and role of rifampicin in amatoxin related mushroom poisoning. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/25911 | DOI: | 10.1080/15563650.2021.1887492 | ORCID: | 0000-0002-6817-7289 | Journal: | Clinical Toxicology | PubMed URL: | 33605821 | Type: | Journal Article | Subjects: | Liver antimicrobials gut and hepatotoxicity other |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.